Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91


Mouse models of diabetic neuropathy.

Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F 3rd, Feldman EL.

Neurobiol Dis. 2007 Dec;28(3):276-85. Epub 2007 Jul 31.


Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?

Jack MM, Ryals JM, Wright DE.

Exp Neurol. 2012 Mar;234(1):62-9. doi: 10.1016/j.expneurol.2011.12.015. Epub 2011 Dec 19.


Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes.

Samuels IS, Bell BA, Pereira A, Saxon J, Peachey NS.

J Neurophysiol. 2015 Feb 15;113(4):1085-99. doi: 10.1152/jn.00761.2014. Epub 2014 Nov 26.


Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.

Schmidt RE, Dorsey DA, Beaudet LN, Frederick KE, Parvin CA, Plurad SB, Levisetti MG.

Am J Pathol. 2003 Nov;163(5):2077-91.


Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.

Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC 3rd, Kretzler M.

Diabetes. 2013 Jan;62(1):299-308. doi: 10.2337/db11-1667. Epub 2012 Nov 8.


Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Wang L, Chopp M, Szalad A, Liu Z, Bolz M, Alvarez FM, Lu M, Zhang L, Cui Y, Zhang RL, Zhang ZG.

Neuroscience. 2011 Oct 13;193:399-410. doi: 10.1016/j.neuroscience.2011.07.039. Epub 2011 Jul 27.


Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.

Negi G, Kumar A, Kaundal RK, Gulati A, Sharma SS.

Neuropharmacology. 2010 Mar;58(3):585-92. doi: 10.1016/j.neuropharm.2009.11.018. Epub 2009 Dec 11.


Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.

Pande M, Hur J, Hong Y, Backus C, Hayes JM, Oh SS, Kretzler M, Feldman EL.

Diabetes. 2011 Jul;60(7):1981-9. doi: 10.2337/db10-1541. Epub 2011 May 26.


Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Wiggin TD, Kretzler M, Pennathur S, Sullivan KA, Brosius FC, Feldman EL.

Endocrinology. 2008 Oct;149(10):4928-37. doi: 10.1210/en.2008-0869. Epub 2008 Jun 26.


Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, Feldman EL.

J Endocrinol. 2013 Jan 2;216(1):1-11. doi: 10.1530/JOE-12-0356. Print 2013 Jan.


Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains.

Mao HZ, Roussos ET, Péterfy M.

Biochim Biophys Acta. 2006 Apr;1762(4):440-6. Epub 2006 Jan 30.


SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Vincent AM, Russell JW, Sullivan KA, Backus C, Hayes JM, McLean LL, Feldman EL.

Exp Neurol. 2007 Dec;208(2):216-27. Epub 2007 Aug 3.


Wld(S) protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice.

Zhu SS, Ren Y, Zhang M, Cao JQ, Yang Q, Li XY, Bai H, Jiang L, Jiang Q, He ZG, Chen Q.

Diabetologia. 2011 Sep;54(9):2440-50. doi: 10.1007/s00125-011-2226-1. Epub 2011 Jul 8.


Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.

Guilford BL, Ryals JM, Wright DE.

Exp Diabetes Res. 2011;2011:848307. doi: 10.1155/2011/848307. Epub 2011 Nov 14.


Peripheral neuropathy in mutant diabetic mouse [C57BL/Ks (db/db)].

Sima AA, Robertson DM.

Acta Neuropathol. 1978 Feb 20;41(2):85-9.


Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.

Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.

Am J Physiol Renal Physiol. 2005 Oct;289(4):F911-21. Epub 2005 Jun 7.


Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL.

Diabetes. 2009 Oct;58(10):2376-85. doi: 10.2337/db09-0047. Epub 2009 Jul 10.


Reduced proliferation and a high apoptotic frequency of pancreatic beta cells contribute to genetically-determined diabetes susceptibility of db/db BKS mice.

Puff R, Dames P, Weise M, Göke B, Seissler J, Parhofer KG, Lechner A.

Horm Metab Res. 2011 May;43(5):306-11. doi: 10.1055/s-0031-1271817. Epub 2011 Mar 16.

Items per page

Supplemental Content

Write to the Help Desk